David Durán Martínez

Prof. David Durán Martínez


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in Stresses
Verified
Journal Article
Open access
PDF file
DMDavid Durán Martínez
David Durán Martínez
AMAdriana Valladares Méndez
Adriana Valladares Méndez
JRJESUS RIVERA
JESUS RIVERA
JCJessica N. Sanchez Carranza
Jessica N. Sanchez Carranza
Cold atmospheric plasma (CAP) has gained attention as a non-invasive therapeutic option in oncology due to its selective cytotoxicity against cancer cells. CAP produces a complex mixture of reactive oxygen and nitrogen species (RONS), which induce oxidative stress, leading to various forms of cell death, including apoptosis, necrosis, autophagy, and ferroptosis. These mechanisms allow CAP to target cancer cells effectively while sparing healthy tissue, making it a versatile tool in cancer treatment. This review explores the molecular pathways modulated by CAP, including PI3K/AKT, MAPK/ERK, and p53, which are crucial in the regulation of cell survival and proliferation. Additionally, in vivo, in vitro, and clinical studies supporting the efficacy of CAP are collected, providing additional evidence on its potential in oncological therapy.

12 November 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DMDavid Durán Martínez
David Durán Martínez
AMAdriana Valladares Mendez
Adriana Valladares Mendez
JRJESUS RIVERA
JESUS RIVERA
JCJessica N. Sanchez Carranza
Jessica N. Sanchez Carranza
Cold atmospheric plasma (CAP) has gained attention as a non-invasive therapeutic option in oncology due to its selective cytotoxicity against cancer cells. CAP produces a complex mixture of reactive oxygen and nitro-gen species (RONS), which induce oxidative stress, leading to various forms of cell death, including apopto-sis, necrosis, autophagy, and ferroptosis. These mechanisms allow CAP to target cancer cells effectively while sparing healthy tissue, making it a versatile tool in cancer treatment. This review explores the molecular pathways modulated by CAP, including PI3K/AKT, MAPK/ERK, and p53, which are crucial in the regulation of cell survival and proliferation. Additionally, in vivo, in vitro and clinical studies supporting the efficacy of CAP are collected, providing additional evidence on its potential in oncological therapy.